Please login to the form below

Not currently logged in
Email:
Password:

idelalisib

This page shows the latest idelalisib news and features for those working in and with pharma, biotech and healthcare.

R&D productivity takes off

R&D productivity takes off

nitro-dihydro-imidazooxazole drug for multidrug-resistant tuberculosis (MDR-TB); Gilead Sciences' Zydelig (idelalisib) for certain types of leukaemia and lymphoma, which inhibits a protein that plays a role in the

Latest news

More from news
Approximately 2 fully matching, plus 13 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Toast TV

Toast TV are experts in communicating the needs of our clients through engaging and beautifully crafted live action and animated...

Latest intelligence

Healthy narratives?
In medical market research we see that most physicians are not early adopters, preferring to wait for their colleagues to adopt new medicines and practices before doing so themselves. There...
Allergies – Always a story
Saycomms looks into the seasonal trend of allergies stories in the media and the communication campaigns launched in UK in 2015....
When is sun safety doing more harm than good?
Say Communications analyses the impact of sun safety campaigns in the news and on consumers...

Infographics